KIRKLAND, WASHINGTON - August 19, 1999 - Radiant Research, a leading
Site Management Organization (SMO), announces the acquisition of Oregon
Research Group-a premier clinical research center in Eugene, Oregon. The
center is directed by Donald L. England, M.D. Dr. England is board
certified in Internal Medicine and Geriatric Medicine and is nationally
recognized for his achievements in research of CNS and gerontology.
Before becoming part of Radiant Research, Oregon Research Group was the
research division of PeaceHealth-a 100-physician multi-specialty practice.
The site will continue to work in close cooperation with the PeaceHealth
physicians, while expanding its sub-contract relationships with other
research investigators in the region. Oregon Research Group opened its
doors in 1987 and has conducted over 250 clinical trials in a variety of
therapeutic areas.
"With Dr. England joining our elite investigator team, Radiant
Research acquires an invaluable resource in the field of CNS-a therapeutic
area where drug development is experiencing tremendous growth," said
Michael Lester, President and CEO of Radiant Research.
"We are excited to become part of this progressive
organization," said Donald England, M.D., Medical Director of the
Oregon Research Group. "We have long maintained an excellent
relationship with the Radiant Research management. We are aware of their
unique ability to not only hand-pick the best research sites in the
industry but also integrate them into one company, while allowing the
necessary degree of autonomy to achieve the perfect mixture of centralized
efficiencies and localized management."
"The endorsement our business model and our strategic direction
receive time and again from the leaders of clinical research further
strengthens our desire to persevere on the path of building an
organization which is, indeed, changing the nature of clinical studies, as
our mission states," added Michael Lester.
###
About Radiant Research
Based near Seattle, Washington, Radiant Research (radiantresearch.com) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant is comprised of more than 30 wholly-owned premier clinical research centers nationwide, employing over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.
| Contact: |
|
Michael K. Lester
Chief Executive Officer
RADIANT RESEARCH
(425) 468-6200 |
Pamela M. Spaniac
Chief Financial Officer
RADIANT RESEARCH
(425) 468-6200 |